Cite
[A Case of Successful Treatment of Recurrent Peritoneal Dissemination of Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Combination Therapy]
MLA
Yoshiteru, Katsura, et al. “[A Case of Successful Treatment of Recurrent Peritoneal Dissemination of Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Combination Therapy].” Gan to Kagaku Ryoho. Cancerchemotherapy, vol. 48, no. 13, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6625cd3ad5afa08d09e7dd7af9360b6a&authtype=sso&custid=ns315887.
APA
Yoshiteru, K., Yutaka, T., Yoshiaki, O., Takuya, S., Go, S., Shinsuke, K., Ryo, I., Kenji, K., Masayuki, H., Keijiro, S., Toru, M., Atsushi, T., Taishi, H., & Kohei, M. (2022). [A Case of Successful Treatment of Recurrent Peritoneal Dissemination of Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Combination Therapy]. Gan to Kagaku Ryoho. Cancerchemotherapy, 48(13).
Chicago
Yoshiteru, Katsura, Takeda Yutaka, Ohmura Yoshiaki, Sakamoto Takuya, Shinke Go, Katsuyama Shinsuke, Ikeshima Ryo, et al. 2022. “[A Case of Successful Treatment of Recurrent Peritoneal Dissemination of Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Combination Therapy].” Gan to Kagaku Ryoho. Cancerchemotherapy 48 (13). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6625cd3ad5afa08d09e7dd7af9360b6a&authtype=sso&custid=ns315887.